title: Current clinical applications of omega-6 and omega-3 fatty acids.
abstract: BACKGROUND
  Recent years have brought a resurgence of research interest in fatty acids, with studied fields running the gamut of human disease. This movement has run in parallel with an increased interest in using nutrition modalities as therapeutic measures, as opposed to their conventional role as energy sources. The aim of this manuscript is to provide a basic review of current clinical applications of omega-6 and omega-3 fatty acids, with a particular focus on the latter.
  
  
  METHODS
  A selective review of the voluminous literature, including randomized controlled trials, meta-analyses, population studies, and case reports, was used to compile data and identify trends in pertinent clinical applications of fatty acid therapy.
  
  
  CONCLUSIONS
  There are a myriad of disorders and maladies that seem to benefit from fatty acid supplementation, specifically omega-3 fatty acids. It has clearly been shown that omega-3 fatty acid supplementation provides a protective benefit in heart disease, and in particular sudden cardiac death. Rheumatoid arthritis (RA) is another disease entity that has been proven to benefit from this nutrition intervention, with improvement in symptoms and diminished nonsteroidal antiinflammatory drug (NSAID) usage. In addition, many psychiatric disorders, particularly schizophrenia and major depressive disorder (MDD), have shown positive results when supplementation has been used as an adjunct to standard pharmacotherapy. The remainder of clinical applications for omega-3 fatty acids requires further investigation. Specifically, according to preliminary clinical evidence, parenteral administration of fatty acids warrants further study.
authors.affiliation: Children's Hospital Boston, 300 Longwood Ave., MA 02115, USA.
authors.forename: Sang
authors.initials: S
authors.lastname: Lee
authors.forename: Kathleen M
authors.initials: KM
authors.lastname: Gura
authors.forename: Sendia
authors.initials: S
authors.lastname: Kim
authors.forename: Danielle A
authors.initials: DA
authors.lastname: Arsenault
authors.forename: Bruce R
authors.initials: BR
authors.lastname: Bistrian
authors.forename: Mark
authors.initials: M
authors.lastname: Puder
mesh_terms: D000818:Animals; D001172:Arthritis, Rheumatoid / Q000517:prevention & control*; D019587:Dietary Supplements; D004195:Disease Models, Animal; D015525:Fatty Acids, Omega-3 / Q000502:physiology / Q000627:therapeutic use; D043371:Fatty Acids, Omega-6 / Q000502:physiology / Q000627:therapeutic use; D006331:Heart Diseases / Q000517:prevention & control*; D006801:Humans; D001523:Mental Disorders / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D015525:Fatty Acids, Omega-3; D043371:Fatty Acids, Omega-6